- II Simpósio Brasileiro de Toxoplasmose - 30 jan. a 01 fev. 2013
- Tercer Congreso Internacional sobre Humanidades Médicas - 15 a 16 mar. 2013
- V Word Congress on Leishmaniasis, 13 a 17 maio 2013.
- 8th European Congress on Tropical Medicine and International Health, 10 a 13 set. 2013.
HANSENÍASE (1) DÜPPRE, N. C. et al. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study. PloS neglected tropical diseases, San Francisco, v. 6, n. 6, p. e1711, June 2012.
(2) MARTINS, M. V. S. B. et al. Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy. PloS neglected tropical diseases, San Francisco, v. 6, n. 4, p. e1616, Apr. 2012. (3) ROCHA, A. da S. et al. Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients. Journal of clinical microbiology, Washington, v. 50, n. 6, p. 1912-1917, June 2012. (4) SANTOS, A. K.; RIBEIRO, A. P.; MONTEIRO, S. The production of social discourse on Hansen' disease and health education materials in Brazil: a skin patch as something harmless or a serious disease? Leprosy review, London, v. 87, n. 1, p. 26-35, Jan./Feb. 2012. (5) COSTA, M. D. et al. Assessment of quality of life of patients with leprosy reactional states treated in a dermatology reference center. Anais brasileiros de dermatologia, Rio de Janeiro, v. 87, n. 1, p. 26-35, Jan./Feb. 2012. (6) QUARESMA, J. A. S. et al. Transforming growth factor ß and apoptosis in leprosy skin lesions: possible relationship with the control of the tissue immune response in the Mycobacterium leprae infection. Microbes and infection, Paris, v. 14, n. 9, p. 696-701, Aug. 2012. (7) SILVA, A. R.et al. Leprosy in Buriticupu, state of Maranhão: active search in the general population. Revista da Sociedade Brasileira de Medicina Tropical, Maranhão, v. 45, n.2, p. 199-202, Feb, 2012. (8) VÉRAS, L. S.et al. Electromyography function, disability degree, and pain in leprosy patients undergoing neural mobilization treatment. Revista da Sociedade Brasileira de Medicina Tropical, Teresina, v.45, n.1, p. 83-88, Feb, 2012 (9) MONTENEGRO, R. M. et al. Reactional state and nutritional profile among leprosy patients in the primary health care system, Greater Vitória. Cadernos de Saúde Pública, Espírito Santo, v. 28, n. 1, p. 31-38, Jan, 2012 (10) CURY, M. R.et al. Spatial analysis of leprosy incidence and associated socioeconomics factors. Revista de Saúde Pública, São Paulo, v. 46, n. 1, p.110-118, Feb, 2012. 
ZOONOSES (1) SAUNDERS, S. E. ; BARTELT-HUNT, S.L.; BARTZ, J.C. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerging infectious diseases , Atlanta, v.18, n. 3, 369-376, Mar. 2012. (2) HUMBLET, M. F. et al . Multidisciplinary and evidence-based method for prioritizing diseases of food-producing animals and zoonoses. Emerging infectious diseases, Atlanta, v.18, n. 4, Apr. 2012 (3) EPP, T.; WALDNER, C. Occupational health hazards in veterinary medicine: zoonoses and other biological hazards. Canadian veterinary journal, Bethesda, v. 53, n. 2, p. 144-150, Feb. 2012. (4) GARCIA, R. C. ; CALDERÓN, N. ; FERREIRA, F. [Consolidation of international guidelines for the management of canine populations in urban areas and proposal of performance indicators]. Revista Panamericana de Salud Pública , Washington, v. 32, n. 2, p. 140-144, Aug. 2012. (5) PALESE, P. ; WANG, T. T. H5N1 influenza viruses: facts, not fear. Proceedings of the National Academy of Sciences of the United States of América, v.109, n. 7, p. 2211-2213, Feb. 2012.
Leia o artigo
(1) DYMOND, E. ; LONG, A.; MCCARTHY, A.; DRAKE, M. J. Developing a new treatment device: how to get an idea to the marketplace. Neurourology and urodynamics, New York, v. 31, n. 4, p. 429-436, Apr. 2012. (2) STAMFORD, A.; CAVALCANTI, M. Decisões judiciais sobre acesso aos medicamentos em Pernambuco. Revista de Saúde Pública, São Paulo, v. 46, n. 5, p.791-799, out. 2012. (3) HELFER, A. P. et al. Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de la Salud publica, Washington, v. 31, n. 3, p. 225-232, mar. 2012. (4) SANVITO, W. L. Indústria farmacêutica: uma abordagem crítica. Revista da Sociedade Brasileira de Clínica Médica. São Paulo, v. 10, n. 4, p. 346-350. jul.-ago. 2012. . (5) MARTINEZ, M. E. M.; REIS, P. C.; SANTOS, D A.; WINTER, E. Avaliação do perfil patentário do emprego de nanotecnologias no setor têxtil. Cadernos de Prospecção, Salvador, v. 5, n. 4, p.185-196, 2012
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
